Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAptitude Regulatory News (APTD)

Share Price Information for Aptitude (APTD)

Share Price is delayed by 15 minutes
Get Live Data
207.00    1.00 (0.49%)
Bid:
206.00
Ask:
214.00
Spread: 8.00 (3.883%)
Market Cap: £109.29m
APTD Live PriceLast checked at - London Stock Exchange

Intraday Aptitude Share Chart

AGM Trading update

24 Apr 2017 07:00

RNS Number : 0157D
Microgen PLC
24 April 2017
Β 

Β 

microgen

www.microgen.com

Β 

24 April 2017

Β 

AGM Trading Update

Β 

Ivan Martin, Chairman of Microgen plc ("Group"), will provide the following trading update at the Annual General Meeting to be held at 9.00 a.m. this morning.

Β 

"The Board is pleased to confirm that each of the Group's two businesses have made a strong start to 2017.

Β 

The Aptitude Software business has built on the excellent progress it achieved in 2016 with a number of successes in both new and existing markets. Aptitude Software has successfully developed its presence in the US healthcare market with two material contracts secured since the start of the year. The opening of this important new market in 2017 complements the continued demand for the Aptitude Revenue Recognition Engine from telcos as they work towards the implementation of IFRS 15 and ASC 606, accounting standards which are effective for annual reporting periods beginning on or after 1 January 2018.

Β 

Microgen Financial Systems continues to focus on growing its Trust & Fund Administration business ("T&FA") through a combination of organic growth and add-on acquisitions. New business progress has continued in 2017 complemented by a number of customers acquired with the add-on acquisitions committing to convert to Microgen 5Series in line with the strategy of the business. In February 2017 the business announced the acquisition of Primacy Corporation, the fifth add-on acquisition within T&FA since December 2014. The integration of Primacy Corporation continues in line with expectations.

Β 

The Board remains confident that the progress at the start of 2017 will continue throughout the year."

Β 

Β 

Contacts

Ivan Martin, Chairman 020-7496-8100

Philip Wood, Chief Financial Officer

Β 

Darius Alexander, FTI Consulting 020-3727-1063

Β 

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
AGMIBMBTMBJTBPR
Date   Source Headline
26th Jul 20237:00 amRNSInterim Results
24th Jul 20235:22 pmRNSHolding(s) in Company
20th Jul 20237:00 amRNSHolding(s) in Company
19th Jul 20237:00 amRNSDirector Retirement
13th Jul 20237:00 amRNSTrading Update and Directorate Changes
23rd Jun 20234:43 pmRNSHolding(s) in Company
16th Jun 20234:22 pmRNSHolding(s) in Company
25th May 20235:22 pmRNSDirector/PDMR Shareholding
24th May 202311:01 amRNSHolding(s) in Company
23rd May 20236:10 pmRNSDirector/PDMR Shareholding
23rd May 20233:27 pmRNSHolding(s) in Company
17th May 202311:24 amRNSResult of AGM
17th May 20237:00 amRNSAGM Statement and Appointment of CFO
2nd May 202311:44 amRNSHolding(s) in Company
24th Apr 20235:13 pmRNSExercise of awards under 2020 Deferred Bonus Plan
20th Apr 202311:30 amRNSGrant of awards under 2020 Deferred Bonus Plan
17th Apr 202311:49 amRNSHolding(s) in Company
17th Apr 20238:32 amRNSHolding(s) in Company
29th Mar 20234:36 pmRNSDirector/PDMR Shareholding
29th Mar 20234:35 pmRNSPrice Monitoring Extension
29th Mar 202311:27 amRNSBLOCK LISTING SIX MONTHLY RETURN
21st Mar 20237:00 amRNSAudited Results for Year Ended 31 December 2022
13th Feb 20235:20 pmRNSHolding(s) in Company
1st Feb 20234:40 pmRNSSecond Price Monitoring Extn
1st Feb 20234:35 pmRNSPrice Monitoring Extension
26th Jan 20237:00 amRNSHolding(s) in Company
24th Jan 20237:00 amRNSFull Year Trading Update and Directorate Change
12th Jan 20239:51 amRNSNew Directorship Notification
24th Nov 20227:00 amRNSGrant of awards under Performance Share Plan
8th Nov 20227:00 amRNSGrant of awards
21st Oct 20224:41 pmRNSSecond Price Monitoring Extn
21st Oct 20224:36 pmRNSPrice Monitoring Extension
28th Sep 20227:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
28th Jul 20227:00 amRNSInterim Results
18th Jul 20227:00 amRNSNotice of Results
31st May 202211:40 amRNSTotal Voting Rights
26th May 20228:56 amRNSHolding(s) in Company
17th May 20221:57 pmRNSDirector/PDMR Shareholding and Total Voting Rights
5th May 20222:10 pmRNSDirector Shareholding
29th Apr 202210:56 amRNSTotal Voting Rights
28th Apr 202212:24 pmRNSResult of AGM and Directorate Change
28th Apr 20227:00 amRNSAGM Statement
12th Apr 202211:50 amRNSBlock Listing Application
11th Apr 20222:30 pmRNSBlock listing Interim Review
4th Apr 20227:00 amRNSGrant of awards under 2020 Deferred Bonus Plan
22nd Mar 20227:00 amRNSDirector/PDMR Shareholding
15th Mar 20227:00 amRNSAudited Preliminary Results
1st Mar 20221:00 pmRNSTotal Voting Rights
1st Feb 202211:05 amRNSTotal Voting Rights
20th Jan 20227:00 amRNSTrading Update and Notice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.